About Nanostring technologies, inc.
NanoString Technologies, Inc. is a leading provider of life science tools for translational research and molecular diagnostics. The company's mission is to catalyze the next biological revolution by improving the human condition through research in spatial biology and in vitro diagnostic applications.
Founded in 2003, NanoString has developed a unique technology platform that enables researchers to analyze complex biological samples with unprecedented precision and sensitivity. The company's nCounter Analysis System uses a novel digital barcoding technology to detect and quantify hundreds of genes or proteins simultaneously from a single sample, without the need for amplification or labeling.
NanoString's technology has been widely adopted by researchers around the world for applications such as gene expression profiling, copy number analysis, miRNA analysis, protein expression profiling, and more. The nCounter system has been used in thousands of studies across a wide range of fields including cancer research, immunology, neuroscience, infectious diseases, and more.
In addition to its research tools business, NanoString is also developing innovative diagnostic products based on its proprietary technology platform. The company's first FDA-cleared diagnostic product is Prosigna®, a breast cancer prognostic test that provides highly accurate information about a patient's risk of recurrence.
NanoString is committed to advancing scientific knowledge and improving patient outcomes through collaboration with academic institutions and industry partners. The company has established partnerships with leading pharmaceutical companies such as Merck KGaA and Bristol-Myers Squibb to develop companion diagnostics for targeted therapies.
With headquarters in Seattle Washington USA , Nanostring Technologies employs over 500 people worldwide who are dedicated to advancing scientific discovery through innovative technologies that improve human health.
In conclusion,Nanostring Technologies Inc.is an innovative life science tool provider that offers unique solutions for translational research as well as molecular diagnostics.Their cutting-edge nCounter Analysis System allows researchers around the world access unprecedented precision,sensitivity,and accuracy when analyzing complex biological samples.Nanostring Technologies' commitment towards advancing scientific knowledge while improving patient outcomes makes them one of the most sought-after companies within their field.With their focus on collaboration with academic institutions,and industry partners,Nanostring Technologies continues pushing boundaries within their field while providing unparalleled service delivery globally.
nanostring.com
